Abstract | AIM: METHODS:
Asthma model was induced by chronic exposure to ovalbumin (OVA) in C57BL/6 mice. The eosinophils in bronchoalveolar lavage (BAL) fluid and lung tissues were counted, IL-5 level in BAL fluid was measured, and CysLT1 and CysLT2 receptor mRNA expressions were detected by semi-quantitative RT-PCR. RESULTS:
Montelukast (6 mg/kg, once per day for 20 d) significantly suppressed the increased eosinophils in BAL fluid and lung tissue, and increased IL-5 level in BAL fluid in OVA challenged mice. OVA challenge increased CysLT1 but decreased CysLT2 receptor mRNA expression. Montelukast inhibited the increased CysLT1 but not the reduced CysLT2 expression after OVA challenge. CONCLUSION:
|
Authors | Yan-Jun Zhang, Lei Zhang, Shao-Bin Wang, Hua-Hao Shen, Er-Qing Wei |
Journal | Acta pharmacologica Sinica
(Acta Pharmacol Sin)
Vol. 25
Issue 10
Pg. 1341-6
(Oct 2004)
ISSN: 1671-4083 [Print] United States |
PMID | 15456537
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2004 Acta Pharmacologica Sinica |
Chemical References |
- Acetates
- Anti-Asthmatic Agents
- Cyclopropanes
- Interleukin-5
- Leukotriene Antagonists
- Membrane Proteins
- Quinolines
- RNA, Messenger
- Receptors, Leukotriene
- Sulfides
- Ovalbumin
- cysteinyl leukotriene receptor 2
- leukotriene D4 receptor
- montelukast
|
Topics |
- Acetates
(pharmacology)
- Animals
- Anti-Asthmatic Agents
(pharmacology)
- Asthma
(chemically induced, metabolism)
- Bronchoalveolar Lavage Fluid
(chemistry)
- Cyclopropanes
- Eosinophils
(metabolism, pathology)
- Interleukin-5
(metabolism)
- Leukocyte Count
- Leukotriene Antagonists
(pharmacology)
- Lung
(metabolism)
- Male
- Membrane Proteins
(antagonists & inhibitors, biosynthesis, genetics)
- Mice
- Mice, Inbred C57BL
- Ovalbumin
- Quinolines
(pharmacology)
- RNA, Messenger
(biosynthesis, genetics)
- Receptors, Leukotriene
(biosynthesis, genetics)
- Sulfides
- Up-Regulation
|